Lv41
600 积分 2022-11-14 加入
Discovery of a dual-target CRBN-mediated degrader for IKZF1/3 and GSPT1 proteins
5小时前
待确认
Development and Mechanistic Evaluation of Cathepsin B‐Activatable Peptide‐Drug Conjugate PROTACs for Targeted Protein Degradation in Malignant Tumors: Advancing Precision Protein Degradation Therapeutics in Oncology
5小时前
已完结
Establishment of Limit of In Vitro Cell Age (LIVCA) for Biologics Manufacturing Process
7天前
已完结
Preface for Special Issue: “Emerging strategies, technologies and approaches for the next generation ADCs”
14天前
已完结
Antibody-Drug Conjugate Overview: a State-of-the-art Manufacturing Process and Control Strategy
14天前
已完结
The landscape of innovative oncology drug targets
14天前
已完结
Selective CDK6 Degradation via the KLHDC2 E3 Ubiquitin Ligase
14天前
已完结
A framework for chemists
14天前
已完结
Discovery of Atirmociclib (PF-07220060): A Potent and Selective CDK4 Inhibitor
14天前
已完结
Degrader-Drug Conjugate (DDC) Mediated Immunochemotherapy for Tumor Treatment
14天前
已完结
皖公网安备34019202002308
